KDM5B and cancer: KDM5A is overexpressed in several cancers including acute myeloid leukemia and lung cancers (Oser et al., 2019; Shokri et al., 2018), KDM5B in breast cancer and melanoma (Roesch et al., 2008; Yamane et al., 2007), and KDM5C in prostate cancers (Stein et al., 2014), as well as metastatic breast and gastric cancers (Xu et al., 2017).